Posted by ICCRR in News on 5/29/2018

The FDA has sent out an updated warning regarding oral teething products (5/23/18):

  • The U.S. Food and Drug Administration (FDA) is warning that over-the-counter (OTC) oral drug products containing benzocaine should not be used to treat infants and children younger than 2 years. 
  • These products carry serious risks and provide little to no benefits for treating oral pain, including sore gums in infants due to teething. 
  • Benzocaine, a local anesthetic, can cause a condition in which the amount of oxygen carried through the blood is greatly reduced. This condition, called methemoglobinemia, can be life-threatening and result in death.

Parents and caregivers should follow the American Academy of Pediatrics’ recommendations for treating teething pain:

  • Gently rub or massage the child’s gums with one of your fingers.
  • Use a firm rubber teething ring.

Topical pain relievers and medications that are rubbed on the gums are not useful because they wash out of a baby’s mouth within minutes. FDA has previously cautioned parents and caregivers to not give certain homeopathic teething tablets to children.

 For more information go to the U.S. Food and Drug Administration website here.


Tags: Oral teething medication , FDA , benzocaine

« Back


Posted by ICCRR in News on 4/2/2019
Shared Visions grants are intended to provide services to Iowa families and children aged birth to five years who are most at-risk.
Read More

Posted by ICCRR in News on 4/1/2019
Volume 4, Issue 2, DHS Child Care Newsletter
Read More

Read More »

Contact Us

Follow the link below to send us a message

Like us, Follow us and Subscribe